Searched for
VERTEX PHARMACEUTICALS
She moved to the US at 11. India-origin CEO in Fortune’s list with Ambani and Adani. Check education and career of Reshma KewalramaniReshma Kewalramani, an Indian-origin CEO, leads Vertex Pharmaceuticals, a Fortune 500 biotech firm, after moving to the US at 11. A Harvard...
US stocks close lower as tariff uncertainty weighsTrump said he and top administration officials will review potential trade deals over the next two weeks to decide which ones to accept.
US stocks bounce back day after Fed's hawkish cut triggers selloffWall Street's main indexes broadly rose at the open on Thursday, a day after the Federal Reserve's projections of fewer-than-expected inter...
Meet world's second highest-paid CEO Nikesh Arora, the Indian-born executive who earns Rs 1,257 croreNikesh Arora, CEO of Palo Alto Networks, emerged as the second highest-paid CEO in the US in 2023, with a total compensation of $151.43 mil...
S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earningsInterest rate-sensitive megacaps gave the tech-heavy Nasdaq a decisive edge. The S&P 500 also closed in positive territory, while the Dow e...
US FDA approves two gene therapies for sickle cell diseaseThe US Food and Drug Administration (FDA) has approved two gene therapies for sickle cell disease, including the first treatment in the US ...
ETPWLA 2023: Raising the curtain on the nominees for the Global Indian of the Year AwardAhead of the Grand Finale of the ETPrime Women Leadership Awards (ETPWLA) 2023, the Economic Times is proud to shine the spotlight on the s...
Anjali Sud, who took over as Vimeo CEO in 2017, believes diversity of opinion is good for business"I embrace what makes me different and view it as an advantage," she said.
S&P 500 ends lower as investors eye stimulus impasseThe Dow Jones Industrial Average fell 0.07% to end at 28,494.2 points, while the S&P 500 lost 0.15% to 3,483.34.
S&P 500 ends lower as investors eye stimulus impasse"Going into the fall it will be difficult for unemployment to make a lot of positive headway because of the lack of stimulus," said Christo...
58 Indian-origin executives employ over 3.6 million globally, account for $1 trillion in revenueIndian-origin business leaders are reaching the pinnacle of corporate success in greater numbers than ever, many use their platforms for so...
Biotech startups choosy on deals with big pharma: Bayer executiveRegulatory and clinical development expertise and the might to take products through the commercialization stages offer a natural edge to b...
Ten stocks in focus in Wednesday's tradeIndian markets are expected to trade higher. Here is a list of ten stocks which are likely to remain in focus today.
- Shasun Pharmaceutical’s UK subsidiary would not be impacted from declining sales of Incevik
Shasun Pharmaceutical’s stock gained 12.6% today after the company came out with an update on its UK subsidiary.
- Dealing Room Buzz: Shashun Pharma, Titan, Bombay Dyeing
ET Now spoke to dealers on institutional and high net worth investors' activity in the dealing room. The following stocks were on their rad...
- India's largest drugmaker Ranbaxy Laboratories ties up with US firm Divine Skin Inc to market hair care product
Ranbaxy Laboratories has tied up with American firm Divine Skin Inc to sell the latter's hair-growth brands through its distribution networ...
- North Maharashtra: Industries gung ho about prospects
North Maharashtra is in the threshold of major change. Propelling this change is a 287-km four-lane highway connecting Igatpuri with the Ma...